09/09/2026
GLP-1 medications have helped many people manage their weight, but new research is highlighting a risk that is not widely discussed.
A 2026 cohort study in the United European Gastroenterology Journal found that GLP-1 receptor agonist use was associated with a 59% higher risk of gallbladder and biliary complications, with the risk primarily driven by gallstone formation.
In his latest article, Mr Stellakis explains why this happens, what symptoms to look out for, and when keyhole gallbladder removal may be the right next step.
Read more here: https://bowelandhernia.co.uk/news/are-weight-loss-medications-increasing-the-risk-of-gallstones/
If you are taking weight loss medication and have developed upper abdominal symptoms, we are happy to help. Call 01926 492969 or email [email protected]